Zacks Investment ResearchTue, 23 Jun 2026 15:55:58 GMTDefinium Stock Soars 50% as Phase III Depression Study Meets Key GoalsDFTX+7.36%
Seeking AlphaMon, 22 Jun 2026 17:02:09 GMTDefinium Therapeutics, Inc. (DFTX) Shareholder/Analyst Call TranscriptDFTX+7.36%
Investors Business DailyMon, 22 Jun 2026 13:41:39 GMTThis Biotech's LSD-Based Drug Just Treated Depression. Now The Stock Is Sky-High.DFTX+7.36%
BenzingaMon, 22 Jun 2026 13:23:29 GMTDefinium Shares Soar After Reporting Positive Phase 3 Results For Single-Dose Depression TreatmentDFTX+7.36%
MarketBeatSat, 23 May 2026 01:02:30 GMTDefinium Therapeutics Eyes Key DT-120 Depression Data, Advances Anxiety ProgramDFTX+7.36%
Seeking AlphaSat, 09 May 2026 14:21:16 GMTDefinium Therapeutics, Inc. (DFTX) Q1 2026 Earnings Call TranscriptDFTX+7.36%
Seeking AlphaMon, 27 Apr 2026 19:41:35 GMTDefinium Therapeutics, Inc. (DFTX) Analyst/Investor Day TranscriptDFTX+7.36%
MarketBeatMon, 27 Apr 2026 15:15:52 GMTThese 3 Psychedelic Stocks Activated After Trump's Executive OrderDFTX+7.36%
CNBCMon, 20 Apr 2026 18:05:39 GMTHow Trump's psychedelics executive order could unlock stalled cannabis reformDFTX+7.36%
The Motley FoolMon, 20 Apr 2026 15:07:47 GMTTrump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to SoarDFTX+7.36%
ForbesMon, 20 Apr 2026 14:45:30 GMTPsychedelic Stocks Surge After Trump Signs Order Fast-Tracking Drug ResearchDFTX+7.36%
Seeking AlphaFri, 17 Apr 2026 17:57:36 GMTDefinium: 'Strong Buy' Maintained On Several Anticipated 2026 MilestonesDFTX+7.36%
